Manesh Raman Patel, MD

Professor of Medicine
Richard Sean Stack, M.D. Distinguished Professor
Chief, Division of Clinical Pharmacology
Chief, Division of Cardiology
Core Faculty in Innovation & Entrepreneurship
Member in the Duke Clinical Research Institute
Campus mail 2301 Erwin Road, Hafs Building, Room 8695, Durham, NC 27710
Phone (919) 681-4441
Email address manesh.patel@duke.edu

Manesh Patel is the Chief of the Division of Cardiology and the Division of Clinical Pharmacology.  His clinical interests include diagnostic and interventional coronary angiography, peripheral angiography and endovascular intervention.  His is involved in several clinical trials involving patients with cardiovascular disease and in cardiac imaging.  He is also the Chair of the American College of Cardiology Task Force for Appropriate Use Criteria for Cardiovascular Procedures and is Chair of the American Heart Association Diagnostic and Interventional Cath Committee.

Patel's interest in cardiac imaging, quality of care, cardiac devices is also evident in his research.  His integration of these efforts into his roles at Duke was recognized in 2010 when he received the prestigious Duke Cardiology Fellowship Mentor Award.   In 2011, Dr. Patel was named the endowed John Bush Simpson Assistant Professor of Cardiology.  In 2013, Dr. Patel received the Robert M. Califf Faculty clinical research Award.

Currently, Dr. Patel is leading an effort to redesign the delivery of care to patients undergoing invasive catheterization procedures in the health system with a specific aim of measure and providing individualized, patient centered, innovative, and efficient care.

In Their Words

Education and Training

  • Fellow in Cardiology, Medicine, Duke University, 2002 - 2006
  • Fellow in Cardiology, Medicine, Duke University, 2000 - 2001
  • Medical Resident, Medicine, Duke University, 1997 - 2000
  • M.D., Emory University, 1997

Publications

Gutierrez, J Antonio, Gretchen M. Heizer, W Schuyler Jones, Frank W. Rockhold, Kenneth W. Mahaffey, F Gerry R. Fowkes, Jeffrey S. Berger, et al. “CYP2C19 status and risk of major adverse cardiovascular events in peripheral artery disease: Insights from the EUCLID Trial.” Am Heart J 229 (November 2020): 118–20. https://doi.org/10.1016/j.ahj.2020.07.017.

PMID
32950849
Full Text

Kochar, Ajar, Hillary Mulder, Frank W. Rockhold, Iris Baumgartner, Jeffrey S. Berger, Juuso I. Blomster, F Gerry R. Fowkes, et al. “Cause of Death Among Patients With Peripheral Artery Disease: Insights From the EUCLID Trial.” Circ Cardiovasc Qual Outcomes 13, no. 11 (November 2020): e006550. https://doi.org/10.1161/CIRCOUTCOMES.120.006550.

PMID
33176462
Full Text

Malik, Ali O., John A. Spertus, Manesh R. Patel, Gregory J. Dehmer, Kevin Kennedy, and Paul S. Chan. “Potential Association of the ISCHEMIA Trial With the Appropriate Use Criteria Ratings for Percutaneous Coronary Intervention in Stable Ischemic Heart Disease.” Jama Intern Med 180, no. 11 (November 1, 2020): 1540–42. https://doi.org/10.1001/jamainternmed.2020.3181.

PMID
32955575
Full Text

Ferris, Robert L., Yael Flamand, F Christopher Holsinger, Gregory S. Weinstein, Harry Quon, Ranee Mehra, Joaquin J. Garcia, et al. “A novel surgeon credentialing and quality assurance process using transoral surgery for oropharyngeal cancer in ECOG-ACRIN Cancer Research Group Trial E3311.” Oral Oncol 110 (November 2020): 104797. https://doi.org/10.1016/j.oraloncology.2020.104797.

PMID
32679405
Full Text

Narcisse, Dennis I., Elizabeth Hope Weissler, Jennifer A. Rymer, Ehrin J. Armstrong, Eric A. Secemsky, William A. Gray, Jihad A. Mustapha, et al. “The impact of chronic kidney disease on outcomes following peripheral vascular intervention.” Clin Cardiol 43, no. 11 (November 2020): 1308–16. https://doi.org/10.1002/clc.23444.

PMID
32780436
Full Text

Rymer, Jennifer A., Hillary Mulder, Kim G. Smolderen, William R. Hiatt, Michael S. Conte, Jeffrey S. Berger, Lars Norgren, et al. “Association of Health Status Scores With Cardiovascular and Limb Outcomes in Patients With Symptomatic Peripheral Artery Disease: Insights From the EUCLID (Examining Use of Ticagrelor in Symptomatic Peripheral Artery Disease) Trial.” J Am Heart Assoc 9, no. 19 (October 20, 2020): e016573. https://doi.org/10.1161/JAHA.120.016573.

PMID
32924754
Full Text

Hoef, Tim P. van de, Joo Myung Lee, Mauro Echavarria-Pinto, Bon-Kwon Koo, Hitoshi Matsuo, Manesh R. Patel, Justin E. Davies, Javier Escaned, and Jan J. Piek. “Non-hyperaemic coronary pressure measurements to guide coronary interventions.” Nature Reviews. Cardiology 17, no. 10 (October 2020): 629–40. https://doi.org/10.1038/s41569-020-0374-z.

PMID
32409779
Full Text

Rymer, Jennifer A., Hillary Mulder, Dennis I. Narcisse, Frank Rockhold, William R. Hiatt, F Gerry Fowkes, Iris Baumgartner, et al. “Association of Disease Progression With Cardiovascular and Limb Outcomes in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial.” Circ Cardiovasc Interv 13, no. 10 (October 2020): e009326. https://doi.org/10.1161/CIRCINTERVENTIONS.120.009326.

PMID
33040584
Full Text

Cho, Min Soo, Jae-Hyung Roh, Hanbit Park, Sang-Cheol Cho, Do-Yoon Kang, Pil Hyung Lee, Jung-Min Ahn, et al. “Practice Pattern, Diagnostic Yield, and Long-Term Prognostic Impact of Coronary Computed Tomographic Angiography.” J Am Heart Assoc 9, no. 18 (September 15, 2020): e016620. https://doi.org/10.1161/JAHA.120.016620.

PMID
32896194
Full Text

Fudim, Marat, Richard L. Boortz-Marx, Arun Ganesh, Adam D. DeVore, Chetan B. Patel, Joseph G. Rogers, Aubrie Coburn, et al. “Splanchnic Nerve Block for Chronic Heart Failure.” Jacc Heart Fail 8, no. 9 (September 2020): 742–52. https://doi.org/10.1016/j.jchf.2020.04.010.

PMID
32535123
Full Text

Pages